EXACT Therapeutics AS
Biopharma firm using ultrasound to enhance drug delivery for oncology via its ACT® platform.
EXTX | OL
Overview
Corporate Details
- ISIN(s):
- NO0010852205 (+1 more)
- LEI:
- 2138006ZE5JAL39AGD55
- Country:
- Norway
- Address:
- Østre Aker vei 19, 0581 Oslo
- Website:
- https://www.exact-tx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
EXACT Therapeutics AS is a clinical-stage biopharmaceutical company developing a technology platform for targeted therapeutic enhancement called Acoustic Cluster Therapy (ACT®). The company's vision is to become a leading precision medicine company by utilizing ultrasound to improve drug delivery in oncology. The proprietary ACT® platform uses a biomechanical mode of action to increase the uptake of co-administered drugs from blood vessels into the surrounding cancer tissue without damaging capillary walls. This technology is designed to be compatible with existing hospital ultrasound systems, requires no drug reformulation, and has shown potential in targeting tumors and crossing the blood-brain barrier. A key focus area is pancreatic cancer, with a clinical program in Phase 2 trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-25 12:57 |
EXACT Therapeutics to present company update - Attachment: 251125 Exact Therap…
|
English | 1.5 MB | ||
| 2025-11-25 12:57 |
EXACT Therapeutics to present company update
|
English | 1.1 KB | ||
| 2025-11-24 08:25 |
EXACT Therapeutics AS: New option program and receipt of share options by prima…
|
English | 112.5 KB | ||
| 2025-11-24 08:25 |
EXACT Therapeutics AS: New option program and receipt of share options by prima…
|
English | 2.2 KB | ||
| 2025-09-25 08:00 |
EXACT Therapeutics first half 2025 interim results - Attachment: EXACT Therape…
|
English | 743.7 KB | ||
| 2025-09-25 08:00 |
EXACT Therapeutics first half 2025 interim results
|
English | 1.4 KB | ||
| 2025-09-18 08:00 |
EXACT Therapeutics’ Phase 2 trial to be presented at the 2025 AACR Special Conf…
|
English | 2.0 KB | ||
| 2025-09-09 08:00 |
EXACT Therapeutic’s Acoustic Cluster Therapy to be presented at the Ninth Inter…
|
English | 2.0 KB | ||
| 2025-08-12 08:30 |
EXACT Therapeutics to Present at the European Society for Medical Oncology (ESM…
|
English | 1.8 KB | ||
| 2025-08-11 11:08 |
Financial calendar
|
English | 430 bytes | ||
| 2025-07-08 08:30 |
EXACT Therapeutics announces grant of core patent in the U.S.
|
English | 1.9 KB | ||
| 2025-06-24 08:00 |
EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients w…
|
English | 3.0 KB | ||
| 2025-06-13 12:09 |
EXACT Therapeutics AS: Primary insider notification - Attachment: Notification …
|
English | 41.4 KB | ||
| 2025-06-13 12:09 |
EXACT Therapeutics AS: Primary insider notification
|
English | 1.3 KB | ||
| 2025-06-13 12:05 |
EXACT Therapeutics minutes from Annual General Meeting June 13, 2025 - Attachme…
|
Norwegian | 729.7 KB |
Automate Your Workflow. Get a real-time feed of all EXACT Therapeutics AS filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EXACT Therapeutics AS
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EXACT Therapeutics AS via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
